RecruitingNCT06541704
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
PHASE3 · 975 planned enrolment
- Countries listed
- 11
- Registry update
- September 18, 2026
